EPIDEMIOLOGIC REVIEWS, an esteemed publication from Oxford University Press Inc, stands as a beacon in the fields of Epidemiology and Medicine, with a significant focus on synthesizing and analyzing the latest research and developments in these areas since its inception in 1979. This journal, with its ISSN 0193-936X and E-ISSN 1478-6729, is recognized for its high academic rigor, boasting a 2023 Q1 quartile ranking in both Epidemiology and Miscellaneous Medicine, and ranks #25 out of 148 in Scopus's Epidemiology category, placing it in the prestigious 83rd percentile. Although it does not currently offer open access, its subscription options provide comprehensive access to a wealth of epidemiological knowledge, essential for researchers, public health professionals, and students keen on advancing their understanding of health trends and disease patterns. With a commitment to promoting high-quality research and impactful insights, EPIDEMIOLOGIC REVIEWS plays a crucial role in enhancing public health discourse and shaping future epidemiological inquiries.

American Journal of Epidemiology is a premier peer-reviewed journal published by Oxford University Press, focusing on the advancement of epidemiological knowledge and methodology since its inception in 1921. With an ISSN of 0002-9262 and E-ISSN 1476-6256, this influential journal serves as a vital resource for researchers and practitioners worldwide, highlighting significant epidemiological findings and fostering dialogue within the field. Ranked in the Q2 category of Epidemiology and holding a commendable 80th percentile in Scopus' ranking, the journal continues to play a significant role in shaping public health policies and practices. Although the journal is not open access, it remains accessible through institutional subscriptions, ensuring comprehensive discourse on pressing epidemiological issues. By continuously publishing high-quality research that informs disease prevention and control strategies, the American Journal of Epidemiology stands at the forefront of epidemiological inquiry, promoting improved health outcomes on a global scale.

ANNALS OF EPIDEMIOLOGY, published by Elsevier Science Inc, stands as a leading journal in the field of epidemiology, with an impressive impact factor that reflects its significant contribution to public health research. With an ISSN of 1047-2797 and an E-ISSN of 1873-2585, the journal has been at the forefront of disseminating high-quality, peer-reviewed research since its inception in 1990. It is consistently ranked in the first quartile (Q1) for epidemiology in 2023, occupying the 29th position out of 148 in the Scopus Medicine category, with a percentage ranking in the 80th percentile. The journal aims to provide a comprehensive platform for the interdisciplinary exchange of pioneering epidemiological studies, exploring diverse health issues and their societal impacts. Researchers, professionals, and students alike will find valuable insights and innovative methodologies within its pages, making it an essential resource for anyone engaged in the study and application of epidemiology. Its headquarters located in the United States (STE 800, 230 Park Ave, New York, NY 10169) further reinforces its influence in the academic community.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

Emerging Themes in Epidemiology, published by BMC, is a prominent open-access journal dedicated to advancing the field of epidemiology since its establishment in 2004. With a commitment to disseminating high-quality research, the journal boasts an impressive Q2 category ranking in Epidemiology according to the latest Scopus rankings, positioning it within the top tier of scholarly journals in the field. Operating from the United Kingdom, it serves as a vital platform that promotes wide accessibility to essential research findings, fostering collaboration among researchers, healthcare professionals, and students alike. Its open access model ensures that studies are available to a global audience, addressing critical health issues and enhancing public health strategies. As the journal converges its themes from 2004 to 2023, it remains at the forefront of epidemiological research, exploring innovative methodologies and emerging trends that influence health outcomes worldwide.

Ophthalmic Epidemiology, published by Taylor & Francis Inc, stands as a crucial platform in the fields of ophthalmology and epidemiology, with the journal's pivotal contributions recognized in its esteemed category quartiles, ranking Q1 in Ophthalmology and Q2 in Epidemiology for 2023. Since its inception in 1994, the journal has provided a multidisciplinary approach to understanding the distribution and determinants of ocular diseases, thereby informing public health practices and clinical interventions. With a commitment to disseminating high-impact research, it holds a Scopus rank of #45/137 in Ophthalmology and engages a global audience of researchers, practitioners, and students dedicated to advancing the field. Although it is not an open-access journal, Ophthalmic Epidemiology remains a vital resource for innovative studies and reviews that help shape evidence-based strategies to combat vision-related public health issues.

Indian Journal of Public Health, published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the fields of public health, epidemiology, and health policy. With a history spanning over six decades, since its inception in 1961, this esteemed journal offers significant insights into various health-related issues affecting the Indian population and beyond. As an Open Access journal since 2010, it ensures that crucial research findings are accessible to a global audience, promoting collaboration and knowledge sharing among researchers, professionals, and students. The journal currently holds a respectable status with a 2023 ranking in the Q3 category in epidemiology, health policy, medicine (miscellaneous), and public health, environmental and occupational health, placing it among the noteworthy publications in its field. With impressive Scopus rankings and an aim to drive public health discourse, the Indian Journal of Public Health is an essential platform for those dedicated to advancing public health practices and policies.

Preventing Chronic Disease (ISSN: 1545-1151, E-ISSN: 1545-1151) is a premier open-access journal published by the CENTERS FOR DISEASE CONTROL & PREVENTION in the United States. Since its inception in 2004, this journal has played a vital role in disseminating research focused on the prevention of chronic diseases, offering insights into innovative public health strategies and policies. With a strong commitment to advancing health knowledge, it has achieved a notable impact factor that reinforces its significance—ranking in the Q1 category for both Health Policy and Public Health, Environmental, and Occupational Health as of 2023. With Scopus rankings placing it in the top 13% and 16% in its respective categories, Preventing Chronic Disease serves as a crucial platform for researchers, professionals, and students dedicated to combating chronic conditions. The journal's open-access model ensures that its valuable findings are accessible to a wide audience, fostering collaboration and innovation in public health research and practice.

The Lancet Regional Health-Europe is a prestigious academic journal published by Elsevier, dedicated to advancing research in the fields of Health Policy, Internal Medicine, and Oncology. As part of a reputable series that focuses on regional health issues, it aims to publish high-quality, peer-reviewed articles that contribute to the understanding and improvement of health systems across Europe. With an impressive impact factor reflected in its Q1 quartile rankings for 2023—ranking #2 in Health Policy, #8 in Internal Medicine, and #22 in Oncology—it is recognized for its significant contribution to cutting-edge research. The journal offers open access options, ensuring that findings are widely disseminated and accessible to researchers, healthcare professionals, and policy-makers alike. By fostering collaboration and interdisciplinary discourse, The Lancet Regional Health-Europe serves as an essential platform for innovative solutions and strategies in health care that address the unique challenges faced within the European context, making it an invaluable resource for academics and practitioners dedicated to public health advancement.

Clinical Epidemiology and Global Health, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a leading open-access journal dedicated to the dissemination of research in the crucial fields of epidemiology and global health. With an ISSN of 2452-0918 and an E-ISSN of 2213-3984, this journal has been a platform for innovative studies since its inception in 2013, converging into a comprehensive resource through 2024. Operating from the Netherlands and ensuring accessibility from anywhere in the world since its transition to an open-access model in 2021, it fosters the global exchange of knowledge. The journal's impact is reflected in its current quartile rankings, including Q2 in Public Health, Environmental and Occupational Health and Q3 in Epidemiology, Infectious Diseases, and Microbiology. With a growing reputation bolstered by SCOPUS rankings that place it in the top percentiles, Clinical Epidemiology and Global Health stands as an essential resource for researchers, professionals, and students dedicated to advancing public health and epidemiological research.